NCT06804265 Molecular Biology in the Identification of Pathogens at Reimplantation in the Two-Stage Treatment of Periprosthetic Infections
| NCT ID | NCT06804265 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Periprosthetic Joint Infection (PJI) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-07 |
| Primary Completion | 2028-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-01-07 with a primary completion date of 2028-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to measure the diagnostic accuracy of the Multiplex PCR technique in identifying pathogens during the diagnostic stage of resolving pre-implantation infection, in the context of treatment according to two-stage protocol for PJIs. This evaluation will be conducted by comparing the results obtained by Multiplex PCR with those derived from standard culture examination.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of periprosthetic infection of hip, knee, shoulder on primary or already revised implant. * treatment of infection with two-stage protocol. * Obtaining informed consent * Age ≥18 years Exclusion Criteria: * Isolates obtained during explantation not included in MULTIPLEX PCR panel
Contact & Investigator
Massimiliano - De Paolis, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06804265 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Periprosthetic Joint Infection (PJI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06804265 currently recruiting?
Yes, NCT06804265 is actively recruiting participants. Contact the research team at massimiliano.depaolis@aosp.bo.it for enrollment information.
Where is the NCT06804265 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06804265 clinical trial?
NCT06804265 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Massimiliano - De Paolis, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 100 participants.